PathPresenter, a global image-sharing platform for pathology, has secured $7.5 million in Series A funding to accelerate the adoption of its enterprise pathology workflow solution. The funding round was led by AVANT BIO, with support from Barco NV and Modi Ventures. The investment will be used to enhance platform features, boost interoperability, expand the engineering and commercial teams, and achieve key regulatory milestones.
Founded by dermatopathologist and digital pathology expert Dr. Rajendra Singh, PathPresenter initially started as a free online tool for pathology education. It quickly grew into the world’s largest digital pathology community, boasting over 50,000 users across 172 countries. To meet institutional demands, PathPresenter developed a secure, scalable enterprise platform designed for clinical care, remote consultations, and research. The platform’s vendor-agnostic approach allows it to integrate seamlessly with various systems, offering a comprehensive workflow solution for digital pathology.
Today, PathPresenter supports more than 50 top-tier hospitals, labs, and pharmaceutical companies, enabling efficient digital pathology workflows that connect institutions with global pathology expertise. The platform incorporates cutting-edge artificial intelligence (AI) algorithms to improve patient outcomes and create new revenue streams from digital pathology investments. By democratizing access to global pathology knowledge, PathPresenter aims to enhance clinical care, education, and research through its innovative, AI-driven enterprise solution.